| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IJPHARM.2010.05.005 |
| P698 | PubMed publication ID | 20471464 |
| P2093 | author name string | Ning Li | |
| Xin Tang | |||
| Mi Wang | |||
| Wei-San Pan | |||
| Jun-Jie Peng | |||
| Xiao-Ning Zhang | |||
| Yu-Sheng Pan | |||
| Chun-Yang Zhuang | |||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bioavailability | Q461809 |
| P304 | page(s) | 179-185 | |
| P577 | publication date | 2010-05-13 | |
| P1433 | published in | International Journal of Pharmaceutics | Q6051539 |
| P1476 | title | Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability | |
| P478 | volume | 394 |
| Q41987567 | A gastrointestinal transit study on amphotericin B-loaded solid lipid nanoparticles in rats |
| Q37066550 | Advanced drug delivery to the lymphatic system: lipid-based nanoformulations |
| Q38406190 | Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs |
| Q38636886 | Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases. |
| Q99565937 | An ATF24 peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment |
| Q48273811 | Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks. |
| Q38558905 | Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine |
| Q35957617 | Carvedilol nano lipid carriers: formulation, characterization and in-vivo evaluation |
| Q53490135 | Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. |
| Q37642547 | Delivery of acetylthevetin B, an antitumor cardiac glycoside, using polymeric micelles for enhanced therapeutic efficacy against lung cancer cells |
| Q35123659 | Development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether |
| Q37729317 | Development of ionic-complex-based nanostructured lipid carriers to improve the pharmacokinetic profiles of breviscapine |
| Q93025972 | Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity |
| Q36191349 | Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine |
| Q42593696 | Effect of particle size on oral absorption of carvedilol nanosuspensions: in vitro and in vivo evaluation |
| Q33662801 | Essential oil-mediated glycerosomes increase transdermal paeoniflorin delivery: optimization, characterization, and evaluation in vitro and in vivo |
| Q40262440 | Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles |
| Q60927375 | Formulation and clinical investigation of optimized vinpocetine lyoplant-tabs: new strategy in development of buccal solid dosage form |
| Q34092136 | Formulation and evaluation of celastrol-loaded liposomes. |
| Q37053563 | Formulation design, preparation, and in vitro and in vivo characterizations of β-Elemene-loaded nanostructured lipid carriers |
| Q39369529 | Formulation, characterization and permeability study of nano particles of lipo-endomorphin-1 for oral delivery. |
| Q57273335 | Glucosamine derivative modified nanostructured lipid carriers for targeted tumor delivery |
| Q38340831 | Immunosuppressive drug therapy--biopharmaceutical challenges and remedies |
| Q91662557 | In Situ Hexosomal Gel as A Promising Tool to Ameliorate the Transnasal Brain Delivery of Vinpocetine: Central Composite Optimization and In Vivo Biodistribution |
| Q38619134 | Inhalable nanocomposite microparticles: preparation, characterization and factors affecting formulation |
| Q38246043 | Insights on novel particulate self-assembled drug delivery beads based on partial inclusion complexes between triglycerides and cyclodextrins |
| Q37262298 | Intravenous microemulsion of docetaxel containing an anti-tumor synergistic ingredient (Brucea javanica oil): formulation and pharmacokinetics |
| Q58737777 | Lipid nanoparticles loading triptolide for transdermal delivery: mechanisms of penetration enhancement and transport properties |
| Q57464672 | Lyophilized Hybrid Nanostructured Lipid Carriers to Enhance the Cellular Uptake of Verapamil: Statistical Optimization and In Vitro Evaluation |
| Q90632582 | Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review |
| Q38199540 | Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration |
| Q85375050 | Nanostructured lipid carrier based topical gel of Ganoderma Triterpenoids for frostbite treatment |
| Q43762449 | Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam |
| Q38210565 | Nanostructured lipid carriers and their current application in targeted drug delivery |
| Q37602960 | Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats |
| Q35686436 | Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanum |
| Q38038902 | Nanostructured lipid carriers system: recent advances in drug delivery. |
| Q26774831 | Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs |
| Q37474497 | Nanostructured lipid carriers: versatile oral delivery vehicle |
| Q26783306 | Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease |
| Q38349734 | Oral bioavailability: issues and solutions via nanoformulations |
| Q59125766 | Orlistat-loaded solid SNEDDS for the enhanced solubility, dissolution, and in vivo performance |
| Q38976681 | PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A. |
| Q36154469 | Preparation and Characterization of Loperamide-Loaded Dynasan 114 Solid Lipid Nanoparticles for Increased Oral Absorption In the Treatment of Diarrhea |
| Q34105924 | Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo |
| Q30406598 | Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement |
| Q60939821 | Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability |
| Q46936967 | Preparation and optimization of triptolide-loaded solid lipid nanoparticles for oral delivery with reduced gastric irritation. |
| Q38757246 | Process optimization and photostability of silymarin nanostructured lipid carriers: effect on UV-irradiated rat skin and SK-MEL 2 cell line. |
| Q50094521 | QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques. |
| Q46577113 | Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement |
| Q34733880 | Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery |
| Q90675994 | Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages |
| Q91866131 | Spray-Dried Silica Xerogel Nanoparticles as a Promising Gastroretentive Carrier System for the Management of Chemotherapy-Induced Nausea and Vomiting |
| Q57793516 | Stimuli-responsive lipid-based magnetic nanovectors increase apoptosis in glioblastoma cells through synergic intracellular hyperthermia and chemotherapy |
| Q59121266 | Subacute Toxicity Profile of Lacidipine Nanoformulation in Wistar Rats |
| Q41667095 | The Improvement of Skin Whitening of Phenylethyl Resorcinol by Nanostructured Lipid Carriers |
| Q99565139 | The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs |
| Q41889403 | The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations. |
| Q34999680 | Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa) |
Search more.